These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27744462)

  • 21. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
    Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
    Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
    Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
    Dohin B; Garin C; Vanhems P; Kohler R
    Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin type A for the treatment of spasticity in children with cerebral palsy].
    Dimitrijević L; Stanković I; Zivković V; Mikov A; Colović H; Janković I
    Vojnosanit Pregl; 2007 Aug; 64(8):513-8. PubMed ID: 17874717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.
    Ferrari A; Maoret AR; Muzzini S; Alboresi S; Lombardi F; Sgandurra G; Paolicelli PB; Sicola E; Cioni G
    Res Dev Disabil; 2014 Oct; 35(10):2505-13. PubMed ID: 24995688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating Functional Outcomes of Botulinum Toxin Type A Injection Combined with Occupational Therapy in the Upper Limbs of Children with Cerebral Palsy: A 9-Month Follow-Up from the Perspectives of Both Child and Caregiver.
    Lin YC; Huang CY; Lin IL; Shieh JY; Chung YT; Chen KL
    PLoS One; 2015; 10(11):e0142769. PubMed ID: 26599003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review.
    Park ES; Rha DW
    Yonsei Med J; 2006 Oct; 47(5):589-603. PubMed ID: 17066503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects.
    Papageorgiou E; Peeters N; Staut L; Molenaers G; Ortibus E; Van Campenhout A; Desloovere K
    Eur J Paediatr Neurol; 2024 Mar; 49():131-140. PubMed ID: 38518417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.
    Ryll U; Bastiaenen C; De Bie R; Staal B
    Dev Med Child Neurol; 2011 Mar; 53(3):210-6. PubMed ID: 21291464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.
    Blaszczyk I; Foumani NP; Ljungberg C; Wiberg M
    Toxins (Basel); 2015 Nov; 7(11):4645-54. PubMed ID: 26561833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
    Park ES; Park CI; Kim DY; Kim YR
    Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upper limb corticomotor projections and physiological changes that occur with botulinum toxin-A therapy in children with hemiplegic cerebral palsy.
    Redman TA; Gibson N; Finn JC; Bremner AP; Valentine J; Thickbroom GW
    Eur J Neurol; 2008 Aug; 15(8):787-91. PubMed ID: 18684310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin type A in children. New indication for limb spasticity.
    Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral Cerebral Palsy: an explorative study.
    Speth L; Janssen-Potten Y; Leffers P; Rameckers E; Defesche A; Winkens B; Becher J; Smeets R; Vles JS
    Eur J Paediatr Neurol; 2015 May; 19(3):337-48. PubMed ID: 25661064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
    Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
    Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: a randomized pilot study.
    Bandholm T; Jensen BR; Nielsen LM; Rasmussen H; Bencke J; Curtis D; Pedersen SA; Sonne-Holm S
    NeuroRehabilitation; 2012; 30(4):277-86. PubMed ID: 22672941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
    Copeland L; Edwards P; Thorley M; Donaghey S; Gascoigne-Pees L; Kentish M; Cert G; Lindsley J; McLennan K; Sakzewski L; Boyd RN
    J Pediatr; 2014 Jul; 165(1):140-146.e4. PubMed ID: 24630348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
    Alexander C; Elliott C; Valentine J; Stannage K; Bear N; Donnelly CJ; Shipman P; Reid S
    Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.
    Mathevon L; Declemy A; Laffont I; Perennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):241-251. PubMed ID: 30980953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.